• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症是否与全因死亡率和功能残疾风险增加有关?

Is sarcopenia associated with an increased risk of all-cause mortality and functional disability?

作者信息

Kelley George A, Kelley Kristi S

机构信息

Department of Biostatistics, West Virginia University, Morgantown, WV, United States.

出版信息

Exp Gerontol. 2017 Oct 1;96:100-103. doi: 10.1016/j.exger.2017.06.008. Epub 2017 Jun 21.

DOI:10.1016/j.exger.2017.06.008
PMID:28647519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5551458/
Abstract

BACKGROUND

While a recent meta-analysis of observational studies reported a statistically significant association between sarcopenia and both all-cause mortality and functional decline, a recently developed inverse heterogeneity (IVhet) model has been shown to be more valid than the traditional random-effects model used.

OBJECTIVE

The objective of this short report was to use a previous meta-analysis to compare the two approaches.

METHODS

Aggregate data meta-analysis of prospective observational studies conducted in any setting. Men and women 60years of age and older in which all-cause mortality (12 studies, 14,169 participants) or functional decline (6 studies, 8561 participants) was assessed. Using the IVhet model, pooling of previous studies regarding the association between sarcopenia and all-cause mortality as well as functional decline. Absolute and relative differences between IVhet and random-effects results were also calculated as well as influence analysis with each study deleted once. Non-overlapping 95% confidence intervals (CI) for odds ratios (OR) were considered statistically significant.

RESULTS

Sarcopenia was associated with an increased risk for all-cause mortality (OR=3.64, 95% CI=2.94 to 4.51) and functional decline (OR=2.58, 95% CI=1.33 to 4.99). Compared to the random-effects model, the OR was slightly higher (0.04 or 1.1%) but with wider CI (0.16 or 11.3%) for all-cause mortality and 0.45 (14.9%) lower with a CI that was 0.34 (10.2%) wider for functional decline. With each study deleted from the model once, results remained statistically significant for both all-cause mortality and functional decline.

CONCLUSION

These results provide additional and more accurate evidence in support of an association between sarcopenia and an increased risk for both all-cause mortality and functional decline.

摘要

背景

尽管最近一项观察性研究的荟萃分析报告称,肌肉减少症与全因死亡率和功能衰退之间存在统计学上的显著关联,但一种新开发的逆异质性(IVhet)模型已被证明比所使用的传统随机效应模型更有效。

目的

本简短报告的目的是利用先前的一项荟萃分析来比较这两种方法。

方法

对在任何环境中进行的前瞻性观察性研究进行汇总数据荟萃分析。评估了60岁及以上男性和女性的全因死亡率(12项研究,14169名参与者)或功能衰退(6项研究,8561名参与者)。使用IVhet模型,汇总先前关于肌肉减少症与全因死亡率以及功能衰退之间关联的研究。还计算了IVhet和随机效应结果之间的绝对和相对差异,以及每次删除一项研究后的影响分析。比值比(OR)的非重叠95%置信区间(CI)被认为具有统计学意义。

结果

肌肉减少症与全因死亡率增加风险(OR=3.64,95%CI=2.94至4.51)和功能衰退(OR=2.58,95%CI=1.33至4.99)相关。与随机效应模型相比,全因死亡率的OR略高(0.04或1.1%),但CI更宽(0.16或11.3%);功能衰退的OR低0.45(14.9%),CI宽0.34(10.2%)。每次从模型中删除一项研究后,全因死亡率和功能衰退的结果仍具有统计学意义。

结论

这些结果提供了更多且更准确的证据,支持肌肉减少症与全因死亡率和功能衰退增加风险之间的关联。

相似文献

1
Is sarcopenia associated with an increased risk of all-cause mortality and functional disability?肌肉减少症是否与全因死亡率和功能残疾风险增加有关?
Exp Gerontol. 2017 Oct 1;96:100-103. doi: 10.1016/j.exger.2017.06.008. Epub 2017 Jun 21.
2
Aerobic Exercise and Cancer-Related Fatigue in Adults: A Reexamination Using the IVhet Model for Meta-analysis.有氧运动与成人癌症相关疲劳:使用IVhet模型进行元分析的重新审视
Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):281-283. doi: 10.1158/1055-9965.EPI-16-0885. Epub 2016 Dec 1.
3
Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study.衰弱高龄老年人(≥80 岁)的肌少症与死亡风险:来自 ilSIRENTE 研究的结果。
Age Ageing. 2013 Mar;42(2):203-9. doi: 10.1093/ageing/afs194. Epub 2013 Jan 15.
4
Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis.肌少症作为养老院老年居民全因死亡率的预测因子:系统评价和荟萃分析。
BMJ Open. 2018 Nov 12;8(11):e021252. doi: 10.1136/bmjopen-2017-021252.
5
Sarcopenia Is Associated With Incident Disability, Institutionalization, and Mortality in Community-Dwelling Older Men: The Concord Health and Ageing in Men Project.肌肉减少症与社区居住老年男性的残疾、机构化和死亡率相关:康科德男性健康与老龄化项目
J Am Med Dir Assoc. 2015 Jul 1;16(7):607-13. doi: 10.1016/j.jamda.2015.02.006. Epub 2015 Mar 26.
6
7
Consequences of sarcopenia.肌肉减少症的后果。
Clin Geriatr Med. 2011 Aug;27(3):387-99. doi: 10.1016/j.cger.2011.03.006. Epub 2011 May 14.
8
Sarcopenia is associated with disability status-results from the KORA-Age study.肌少症与残疾状况相关:来自 KORA-Age 研究的结果。
Osteoporos Int. 2017 Jul;28(7):2069-2079. doi: 10.1007/s00198-017-4027-y. Epub 2017 Apr 6.
9
Multicity study of air pollution and mortality in Latin America (the ESCALA study).拉丁美洲空气污染与死亡率的多城市研究(ESCALA研究)。
Res Rep Health Eff Inst. 2012 Oct(171):5-86.
10
Sarcopenia and mortality in older people living in a nursing home in Turkey.土耳其养老院老年人肌少症与死亡率的关系。
Geriatr Gerontol Int. 2017 Jul;17(7):1118-1124. doi: 10.1111/ggi.12840. Epub 2016 Jul 20.

引用本文的文献

1
RANK-ligand inhibition to combat sarcopenia with underlying osteoporosis: a study protocol for a randomized, double-blind, double-dummy, active-controlled trial.通过抑制核因子κB受体活化因子配体治疗伴骨质疏松症的肌少症:一项随机、双盲、双模拟、活性对照试验的研究方案
Trials. 2025 Aug 4;26(1):269. doi: 10.1186/s13063-025-08976-7.
2
Creatinine and cystatin C-based indices for predicting sarcopenia, frailty and disability in older community-dwelling adults.基于肌酐和胱抑素C预测社区居住老年成年人肌肉减少症、衰弱和残疾的指标
J Nutr Health Aging. 2025 Jul 24;29(9):100635. doi: 10.1016/j.jnha.2025.100635.
3
Prognostic and Associative Significance of Malnutrition in Sarcopenia: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis.肌肉减少症的健康结局:一项系统评价与荟萃分析
PLoS One. 2017 Jan 17;12(1):e0169548. doi: 10.1371/journal.pone.0169548. eCollection 2017.
2
Meta-analysis in clinical trials revisited.再谈临床试验中的荟萃分析。
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45. doi: 10.1016/j.cct.2015.09.002. Epub 2015 Sep 4.
3
Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model.异质性临床试验的Meta分析进展I:逆方差异质性模型
肌少症中营养不良的预后及关联意义:一项系统评价与荟萃分析
Adv Nutr. 2025 May;16(5):100428. doi: 10.1016/j.advnut.2025.100428. Epub 2025 Apr 11.
4
Association between urinary volatile organic compound metabolites and sarcopenia in the US general population: a cross-sectional NHANES study from 2011 to 2018.美国普通人群中尿挥发性有机化合物代谢物与肌肉减少症之间的关联:一项2011年至2018年的横断面美国国家健康与营养检查调查研究
Sci Rep. 2025 Mar 28;15(1):10735. doi: 10.1038/s41598-025-94622-w.
5
Association of sarcopenia with basic activities of daily living and dyspnea-related limitations in patients with interstitial lung disease.间质性肺疾病患者中肌肉减少症与日常生活基本活动及呼吸困难相关限制的关联。
J Thorac Dis. 2025 Feb 28;17(2):564-575. doi: 10.21037/jtd-24-1631. Epub 2025 Feb 24.
6
Association between sarcopenia and cardiovascular disease according to menopausal status: findings from the China Health and Retirement Longitudinal Study (CHARLS).根据绝经状态分析肌肉减少症与心血管疾病之间的关联:来自中国健康与养老追踪调查(CHARLS)的结果
BMC Public Health. 2025 Feb 22;25(1):730. doi: 10.1186/s12889-025-21933-y.
7
Melatonin Ameliorates Age-Related Sarcopenia via the Gut-Muscle Axis Mediated by Serum Lipopolysaccharide and Metabolites.褪黑素通过血清脂多糖和代谢产物介导的肠-肌轴改善与年龄相关的肌肉减少症。
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13722. doi: 10.1002/jcsm.13722.
8
Age‑related changes in endoplasmic reticulum stress response‑associated protein expression in rat tibial nerves.大鼠胫神经内质网应激反应相关蛋白表达的年龄相关性变化
Biomed Rep. 2025 Jan 21;22(3):50. doi: 10.3892/br.2025.1928. eCollection 2025 Mar.
9
Seeking optimal non-pharmacological interventions for sarcopenia: a systematic review and network meta-analysis.寻找肌肉减少症的最佳非药物干预措施:一项系统评价和网状荟萃分析。
Aging Clin Exp Res. 2025 Jan 15;37(1):24. doi: 10.1007/s40520-024-02920-6.
10
Sarcopenia influences usage of reperfusion treatment in patients with pulmonary embolism aged 75 years and older.肌肉减少症影响75岁及以上肺栓塞患者再灌注治疗的使用情况。
Int J Cardiol Heart Vasc. 2024 Jul 19;53:101470. doi: 10.1016/j.ijcha.2024.101470. eCollection 2024 Aug.
Contemp Clin Trials. 2015 Nov;45(Pt A):130-8. doi: 10.1016/j.cct.2015.05.009. Epub 2015 May 21.
4
An overview of sarcopenia: facts and numbers on prevalence and clinical impact.肌肉减少症概述:患病率及临床影响的事实与数据
J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):129-133. doi: 10.1007/s13539-010-0014-2. Epub 2010 Dec 17.
5
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.肌肉减少症:欧洲定义和诊断共识:老年人肌肉减少症欧洲工作组报告。
Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
6
The healthcare costs of sarcopenia in the United States.美国肌肉减少症的医疗保健成本。
J Am Geriatr Soc. 2004 Jan;52(1):80-5. doi: 10.1111/j.1532-5415.2004.52014.x.
7
Measuring inconsistency in meta-analyses.评估荟萃分析中的异质性
BMJ. 2003 Sep 6;327(7414):557-60. doi: 10.1136/bmj.327.7414.557.
8
Meta-analysis in clinical trials.临床试验中的荟萃分析。
Control Clin Trials. 1986 Sep;7(3):177-88. doi: 10.1016/0197-2456(86)90046-2.